So Who’s in Charge of Medicines in Brussels? Now we know who is to do what regarding health issues in the new European Commission. Or do we? The furore that the new boss of the commission, Jean-Claude Juncker, unleashed with the plans for his new team, weeks before it took office, is still reverberating around Brussels. Peter O’ Donnell reports on the fallout... Read more
Sales Reps and the New Commercial Organization Structural transformations in the life sciences industry have put the traditional sales role under increasing scrutiny, with the most prominent change being a drastic reduction in field force deployments in the US and Europe. This, argues Hay Group's Ian Wilcox, is where opportunity lies... Read more
The Top Medical Innovations for 2015 The Cleveland Clinic once again ended its Medical Innovation Summit with a list of 10 advances most likely to have a major impact on improving patient care in 2015. The 110 voting Cleveland Clinic physicians and scientists share their excitement with Pharm Exec, picking PCSK9 inhibitors for cholesterol reduction, immune checkpoint inhibitor cancer therapies and heart failure treatment angiotensin-receptor neprilysin inhibitor as numbers 4, 6 and 10 on their Top Ten list... Read more
Meeting Patient-Centered Expectations in Europe Patients and patient groups are demanding access to innovations in certain therapy areas, such as the new generation of hepatitis C treatments. But closer involvement of patients—in clinical trials or in other areas of medicines development and delivery—depends itself on how far patient engagement and alertness and goodwill are developed across the broad patient or citizen population .... Read more
